These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34215267)

  • 1. Exploration of the methods of establishing the minimum clinical important difference based on anchor and its application in the quality of life measurement scale QLICP-ES (V2.0) for esophageal cancer.
    Ren D; Wu T; Wan C; Li G; Qi Y; Fang Y; Zhong J
    Health Qual Life Outcomes; 2021 Jul; 19(1):173. PubMed ID: 34215267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of the methods of establishing the minimum clinical important difference based on anchors and their applications in the quality of life measurement scale QLICP-BR (V2.0) for breast cancer.
    Zhou X; Liu Y; Tan J; Hu L; Chen H; Wan C
    Front Oncol; 2023; 13():1123258. PubMed ID: 37051543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing Minimal Clinically Important Differences for the Quality of Life Instrument in Patients With Breast Cancer QLICP-BR (V2.0) Based on Anchor-Based and Distribution-Based Methods.
    Li F; Liu Y; Wan C; Zhou J; Tan J; Chen H
    Front Oncol; 2022; 12():753729. PubMed ID: 35586490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing minimal clinically important differences for the quality of life scale QLICD-SLE for patients with systemic lupus erythematosus based on ROC curve.
    Liu Y; Xue H; Wong W; Ding H; Chen M; Xie T; Wan C
    Sci Rep; 2024 Sep; 14(1):20982. PubMed ID: 39251635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing minimal clinically important differences for the Quality of Life Instrument of Chronic Gastritis QLICD-CG(V2.0) based on distribution-based methods.
    Wu X; Chen Y; Wan C; Yu L; Lei P; Sun X
    BMC Gastroenterol; 2023 May; 23(1):149. PubMed ID: 37173655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases.
    Raman S; Ding K; Chow E; Meyer RM; van der Linden YM; Roos D; Hartsell WF; Hoskin P; Wu JSY; Nabid A; Haas R; Wiggenraad R; Babington S; Demas WF; Wilson CF; Wong RKS; Zhu L; Brundage M
    Qual Life Res; 2018 Apr; 27(4):1089-1098. PubMed ID: 29188483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of minimum clinically important difference in assessing pain, disability, and health state after transforaminal lumbar interbody fusion for degenerative lumbar spondylolisthesis.
    Parker SL; Adogwa O; Paul AR; Anderson WN; Aaronson O; Cheng JS; McGirt MJ
    J Neurosurg Spine; 2011 May; 14(5):598-604. PubMed ID: 21332281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of minimum clinically important difference in pain, disability, and quality of life after extension of fusion for adjacent-segment disease.
    Parker SL; Mendenhall SK; Shau D; Adogwa O; Cheng JS; Anderson WN; Devin CJ; McGirt MJ
    J Neurosurg Spine; 2012 Jan; 16(1):61-7. PubMed ID: 21962034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neck Disability Index, short form-36 physical component summary, and pain scales for neck and arm pain: the minimum clinically important difference and substantial clinical benefit after cervical spine fusion.
    Carreon LY; Glassman SD; Campbell MJ; Anderson PA
    Spine J; 2010 Jun; 10(6):469-74. PubMed ID: 20359958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: cognitive function (FACT-Cog) in breast cancer patients.
    Cheung YT; Foo YL; Shwe M; Tan YP; Fan G; Yong WS; Madhukumar P; Ooi WS; Chay WY; Dent RA; Ang SF; Lo SK; Yap YS; Ng R; Chan A
    J Clin Epidemiol; 2014 Jul; 67(7):811-20. PubMed ID: 24656406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal Clinically Important Differences for American Orthopaedic Foot & Ankle Society Score in Hallux Valgus Surgery.
    Chan HY; Chen JY; Zainul-Abidin S; Ying H; Koo K; Rikhraj IS
    Foot Ankle Int; 2017 May; 38(5):551-557. PubMed ID: 28193121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calculation of the minimal clinically important difference in operated patients with adult spine deformity: advantages of the ROC method and significance of prevalence in threshold selection.
    Larrieu D; Baroncini A; Bourghli A; Pizones J; Kleinstueck FS; Alanay A; Pellisé F; Charles YP; Boissiere L; Obeid I
    Eur Spine J; 2024 Jul; 33(7):2794-2803. PubMed ID: 38842608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the minimum clinically important difference in pain, disability, and quality of life after anterior cervical discectomy and fusion: clinical article.
    Parker SL; Godil SS; Shau DN; Mendenhall SK; McGirt MJ
    J Neurosurg Spine; 2013 Feb; 18(2):154-60. PubMed ID: 23176164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal Clinically Important Difference of the Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF) for Fatigue Worsening in Asian Breast Cancer Patients.
    Chan A; Yo TE; Wang XJ; Ng T; Chae JW; Yeo HL; Shwe M; Gan YX
    J Pain Symptom Manage; 2018 Mar; 55(3):992-997.e2. PubMed ID: 29097274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. King's Brief Interstitial Lung Disease questionnaire: responsiveness and minimum clinically important difference.
    Nolan CM; Birring SS; Maddocks M; Maher TM; Patel S; Barker RE; Jones SE; Walsh JA; Wynne SC; George PM; Man WD
    Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31221807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the minimum clinically important difference for grade I degenerative lumbar spondylolisthesis: insights from the Quality Outcomes Database.
    Asher AL; Kerezoudis P; Mummaneni PV; Bisson EF; Glassman SD; Foley KT; Slotkin JR; Potts EA; Shaffrey ME; Shaffrey CI; Coric D; Knightly JJ; Park P; Fu KM; Devin CJ; Archer KR; Chotai S; Chan AK; Virk MS; Bydon M
    Neurosurg Focus; 2018 Jan; 44(1):E2. PubMed ID: 29290132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of the nasopharyngeal cancer scale among the system of quality of life instruments for cancer patients (QLICP-NA V2.0): combined classical test theory and generalizability theory.
    Wu J; Hu L; Zhang G; Liang Q; Meng Q; Wan C
    Qual Life Res; 2016 Aug; 25(8):2087-100. PubMed ID: 26928910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of minimum clinically important difference for assessing patients with subaxial degenerative cervical spine disease: statistical versus substantial clinical benefit.
    Auffinger B; Lam S; Shen J; Thaci B; Roitberg BZ
    Acta Neurochir (Wien); 2013 Dec; 155(12):2345-54; discussion 2355. PubMed ID: 24136679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the Minimum Clinically Important Difference for the WOMAC Index After TKA?
    Clement ND; Bardgett M; Weir D; Holland J; Gerrand C; Deehan DJ
    Clin Orthop Relat Res; 2018 Oct; 476(10):2005-2014. PubMed ID: 30179956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal clinically important differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL modules in patients with bone metastases undergoing palliative radiotherapy.
    Raman S; Ding K; Chow E; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; DeAngelis C; Wong RKS; Zhu L; Brundage M
    Qual Life Res; 2016 Oct; 25(10):2535-2541. PubMed ID: 27138964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.